المؤلفون: Chie Morimoto, MD, PhD, Hisako Matsumoto, MD, PhD, Natsuko Nomura, MD, PhD, Hironobu Sunadome, MD, PhD, Tadao Nagasaki, MD, PhD, Susumu Sato, MD, PhD, Atsuyasu Sato, MD, PhD, Tsuyoshi Oguma, MD, PhD, Isao Ito, MD, PhD, Mariko Kogo, MD, PhD, Keisuke Tomii, MD, PhD, Tomoko Tajiri, MD, PhD, Kai Ohashi, MSc, Takamitsu Tsukahara, PhD, Toyohiro Hirai, MD, PhD

المصدر: Journal of Allergy and Clinical Immunology: Global, Vol 3, Iss 1, Pp 100194- (2024)

مصطلحات موضوعية: Asthma-COPD overlap, eosinophil-low, mixed granulocytic subtype, sputum microbiome, Immunologic diseases. Allergy, RC581-607

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2772829323001194; https://doaj.org/toc/2772-8293

URL الوصول: https://doaj.org/article/7a43ed5a2cbf4828bb2b4816b2212133

المؤلفون: Shota Takahashi, MD, Yuki Sato, MD, Yoshiharu Sato, PhD, Ryosuke Hirabayashi, MD, Shigeo Hara, MD, PhD, Yutaka Takahashi, MD, PhD, Keisuke Tomii, MD, PhD

المصدر: JTO Clinical and Research Reports, Vol 5, Iss 2, Pp 100639- (2024)

مصطلحات موضوعية: Acquired resistance, Histologic transformation, Osimertinib, Immune checkpoint inhibitor, Case report, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2666364324000092; https://doaj.org/toc/2666-3643

URL الوصول: https://doaj.org/article/1b4e2f74c1db4a6a897f9708f8f0ffaa

المؤلفون: Yuki Sato, MD, Satoru Fujiwara, MD, Akito Hata, MD, Yoko Kida, MD, Takahiro Masuda, MD, Hisanori Amimoto, MD, Hirotaka Matsumoto, MD, Kotoko Miyoshi, MD, Kojiro Otsuka, MD, PhD, Keisuke Tomii, MD, PhD

المصدر: JTO Clinical and Research Reports, Vol 4, Iss 12, Pp 100608- (2023)

مصطلحات موضوعية: Small-cell lung cancer, Immune-related adverse event, Autoantibody, Paraneoplastic autoantibody, Paraneoplastic neurologic syndrome, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2666364323001510; https://doaj.org/toc/2666-3643

URL الوصول: https://doaj.org/article/afe89a5eb7694938a99941a50b7a87ea

المؤلفون: Hiroaki Akamatsu, MD, PhD, Shunsuke Teraoka, MD, Hidetoshi Hayashi, MD, PhD, Daichi Fujimoto, MD, Atsushi Hayata, MD, PhD, Koji Haratani, MD, PhD, Yuichi Ozawa, MD, PhD, Takeshi Yoshida, MD, PhD, Tsutomu Iwasa, MD, PhD, Toshio Shimokawa, MD, Keisuke Tomii, MD, PhD, Kazuhiko Nakagawa, MD, PhD, Nobuyuki Yamamoto, MD, PhD

المصدر: JTO Clinical and Research Reports, Vol 2, Iss 7, Pp 100184- (2021)

مصطلحات موضوعية: Small cell lung cancer, Pembrolizumab, Amrubicin, Refractory, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2666364321000436; https://doaj.org/toc/2666-3643

URL الوصول: https://doaj.org/article/772e441e14ed494d9dc68a90b6f84b8f